Breast cancer treatment: Drug Kisqali approval expanded for ... - NBC News
WEB3 days ago · The drug was found to reduce the risk of a patient's breast cancer coming back by 25%. The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to ...
Breast Cancer May Spread by Recruiting Nearby Sensory Nerves
WEB1 day ago · A new study shows how cells in breast tumors (1) recruit nearby nerves to (2) move into the tumors and (3) help the cancer spread to other parts of the body. The body is packed with sensory nerves that pass sensations like touch, pain, and temperature to the nervous system. Such nerves are tangled through tissues in every organ and many tumors.
New study finds triple-negative breast cancer tumors with an …
WEBApr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
Breast Cancer News - ScienceDaily
WEB5 days ago · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
Estrogen a more powerful breast cancer culprit than we realized
WEBMay 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
WEBJun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
FDA Approves New Therapy for Triple Negative Breast Cancer …
WEBApr 22, 2020 · FDA granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread.
Experimental immunotherapy targets metastatic breast cancer
WEBFeb 1, 2022 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).
Enhertu Effective in HER2-Positive Metastatic Breast Cancer
WEBOct 19, 2021 · In people with metastatic HER2-positive breast cancer, the targeted drug trastuzumab deruxtecan (Enhertu) markedly lengthened progression-free survival compared with trastuzumab emtansine (Kadcycla), new study results show.
New study finds triple-negative breast cancer tumors with an …
WEBApr 2, 2024 · New research suggests that people who have early-stage triple-negative breast cancer and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates.
- Some results have been removed